IL6 and COVID-19: Interleukin-6 (IL-6) isknown to play a critical role in a widerange of diseases such as cardiovascular diseases,24,25 viral infections such as COVID,26 cancer,27 sepsis, and bacterial infection,28 neurological diseases,28 and autoimmune diseases.29 Therapieswhich reduce the effects of IL6 have significantly improved treatmentoutcomes for rheumatoid arthritis and COVID-19.26,30 The timely determination of elevated IL-6 levels offers cliniciansan opportunity to identify individuals at risk for poor outcomesand treat them appropriately.